Indications for Use: This product can be used for the treatment of equine protozoal myeloencephalitis (EPM) in horses.
Dosage and Administration: Marquis (15% w/w ponazuril) is to be used at a dose of 5 mg/kg (2.27 mg/lb) body weight once daily for a period of 28 days. Set the dosage dial according to the horse's weight, and administer the paste on top of the horse’s tongue.
Packaging: The package contains four 127 gram syringe applicators.
Precautions and Side Effects: Prior to treatment, EPM should be distinguished from other diseases that may cause ataxia (incoordination) in horses. Injuries or lameness may also complicate the evaluation of an animal with EPM. In most instances, ataxia due to EPM is asymmetrical and affects the hind limbs.
* Veterinarian note: Clinicians should recognize that clearance of the parasite by ponazuril may not completely resolve the clinical signs attributed to the natural progression of the disease. The prognosis for animals treated for EPM may be dependent upon the severity of disease and the duration of the infection prior to treatment.
Storage and Shelf Life: Store at room temperature.
Meat Withholding: Not for use in horses intended for food.
Drug Type: Rx
Manufacturer: Bayer